补肾通络汤联合厄贝沙坦片治疗慢性肾脏病2~3期临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R692

基金项目:


Clinical Study on Bushen Tongluo Tang Combined with Irbesartan Tablets for Stage 2~3 Chronic Kidney Disease
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察补肾通络汤联合厄贝沙坦片治疗慢性肾脏病(CKD) 2~3 期的临床疗效。方法:选取86 例CKD 2~3 期患者,依据不同治疗方法分为对照组和观察组,每组43 例。对照组给予厄贝沙坦片治疗,观察组在对照组基础上加服补肾通络汤治疗,2 组均连续治疗8 周。比较2 组治疗前后肾小球滤过率(eGFR)、运动耐力及生活质量。结果:治疗后,2 组eGFR 均较治疗前升高(P<0.05),6 min 步行距离(6MWD) 均较治疗前增大(P<0.05);观察组eGFR 高于对照组(P<0.05),6MWD 大于对照组(P<0.05)。治疗后,2 组社会功能、情感职能、躯体疼痛、生理机能、精神健康评分均较治疗前升高,观察组社会功能、情感职能、躯体疼痛、生理机能、精神健康评分均高于对照组,差异均有统计学意义(P<0.05)。结论:补肾通络汤联合厄贝沙坦片能有效改善CKD 2~3 期患者的生活质量和运动耐力,提高eGFR。

    Abstract:

    Abstract: Objective: To observe the clinical effect of the therapy of Bushen Tongluo tang combined with irbesartan tablets on stage 2~3 chronic kidney disease(CKD), and its effect on quality of life and exercise endurance of patients. Methods:A total of 86 patients with stage 2~3 CKD were selected and divided into the control group and the observation group according to different treatment methods,with 43 cases in each group. The control group was treated with irbesartan tablets,and the observation group was additionally treated with Bushen Tongluo tang based on the treatment of the control group. Both groups were treated for eight weeks. Before and after treatment,the estimated glomerular filtration rate(eGFR), exercise endurance and quality of life in the two groups were compared. Results:After treatment,the eGFR levels in both groups were increased when compared with those before treatment(P<0.05),and six-minute walking distance(6MWD) was increased(P<0.05); the eGFR level in the observation group was higher than that in the control group(P<0.05), and the 6MWD was farther(P<0.05). After treatment, the scores of social function, emotional function, bodily pain, physical function,mental health in the two groups were increased when compared with those before treatment,and the scores of social function,emotional function,bodily pain,physical function,mental health in the obseration group were higher than those in the control group, differences being significant(P<0.05). Conclusion: The therapy of Bushen Tongluo tang combined with irbesartan tablets can effectively improve the quality of life, exercise endurance and eGFR level of patients with stage 2~3 CKD.

    参考文献
    相似文献
    引证文献
引用本文

马金强,曹汉华.补肾通络汤联合厄贝沙坦片治疗慢性肾脏病2~3期临床研究[J].新中医,2022,54(2):64-67

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-01-22
  • 出版日期: